126 related articles for article (PubMed ID: 35389533)
1. Cytochrome P450 reaction phenotyping of itraconazole hydroxylation in the dog.
Tonero ME; Li Z; Reinhart JM
J Vet Pharmacol Ther; 2022 May; 45(3):255-264. PubMed ID: 35389533
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
[TBL] [Abstract][Full Text] [Related]
3. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
Damkier P; Hansen LL; Brosen K
Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487
[TBL] [Abstract][Full Text] [Related]
4. In vitro analysis of itraconazole cis-diastereoisomers inhibition of nine cytochrome P450 enzymes: stereoselective inhibition of CYP3A.
Krasulova K; Dvorak Z; Anzenbacher P
Xenobiotica; 2019 Jan; 49(1):36-42. PubMed ID: 29320899
[TBL] [Abstract][Full Text] [Related]
5. Identification of canine cytochrome P-450s (CYPs) metabolizing the tramadol (+)-M1 and (+)-M2 metabolites to the tramadol (+)-M5 metabolite in dog liver microsomes.
Perez Jimenez TE; Mealey KL; Schnider D; Grubb TL; Greene SA; Court MH
J Vet Pharmacol Ther; 2018 Dec; 41(6):815-824. PubMed ID: 30113702
[TBL] [Abstract][Full Text] [Related]
6. Role of itraconazole metabolites in CYP3A4 inhibition.
Isoherranen N; Kunze KL; Allen KE; Nelson WL; Thummel KE
Drug Metab Dispos; 2004 Oct; 32(10):1121-31. PubMed ID: 15242978
[TBL] [Abstract][Full Text] [Related]
7. Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences.
Hay Kraus BL; Greenblatt DJ; Venkatakrishnan K; Court MH
Xenobiotica; 2000 Jun; 30(6):575-88. PubMed ID: 10923860
[TBL] [Abstract][Full Text] [Related]
8. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
9. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
Taguchi K; Konishi T; Nishikawa H; Kitamura S
Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
[TBL] [Abstract][Full Text] [Related]
10. Reaction phenotyping of vinblastine metabolism in dogs.
Achanta S; Maxwell LK
Vet Comp Oncol; 2016 Jun; 14(2):161-9. PubMed ID: 24502418
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
12. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.
Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S
Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578
[TBL] [Abstract][Full Text] [Related]
13. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 1999 Jun; 39(6):567-77. PubMed ID: 10354960
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical aspects of itraconazole metabolism in vitro and in vivo.
Kunze KL; Nelson WL; Kharasch ED; Thummel KE; Isoherranen N
Drug Metab Dispos; 2006 Apr; 34(4):583-90. PubMed ID: 16415110
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
Yamazaki H; Shimada T
Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
[TBL] [Abstract][Full Text] [Related]
16. Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide.
Zhang L; Fitzloff JF; Engel LC; Cook CS
Xenobiotica; 2001 Feb; 31(2):73-83. PubMed ID: 11407536
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 isoforms responsible for the N-deethylation and cyclohexane-hydroxylation of NS-21.
Nakamura A; Hirota T; Morino A; Imaoka S; Funae Y; Yamamoto Y; Tasaki T; Masuda M; Kazusaka A; Fujita S
Xenobiotica; 1999 Mar; 29(3):243-52. PubMed ID: 10219965
[TBL] [Abstract][Full Text] [Related]
18. Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.
Templeton IE; Thummel KE; Kharasch ED; Kunze KL; Hoffer C; Nelson WL; Isoherranen N
Clin Pharmacol Ther; 2008 Jan; 83(1):77-85. PubMed ID: 17495874
[TBL] [Abstract][Full Text] [Related]
19. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
Crewe HK; Ellis SW; Lennard MS; Tucker GT
Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.
Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD
Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]